X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (473) 473
Publication (19) 19
Book Review (5) 5
Book Chapter (3) 3
Dissertation (3) 3
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (279) 279
index medicus (213) 213
anti-xa (194) 194
female (162) 162
hematology (162) 162
male (156) 156
anti-xa activity (130) 130
enoxaparin (123) 123
molecular-weight heparin (110) 110
peripheral vascular disease (109) 109
unfractionated heparin (108) 108
middle aged (100) 100
anticoagulants (98) 98
heparin (94) 94
anticoagulants - therapeutic use (92) 92
factor xa inhibitors (91) 91
venous thromboembolism (91) 91
anticoagulants - administration & dosage (87) 87
thrombosis (80) 80
aged (75) 75
rivaroxaban (70) 70
adult (61) 61
pharmacokinetics (61) 61
partial thromboplastin time (58) 58
low molecular weight heparin (52) 52
prevention (52) 52
low-molecular-weight heparin (51) 51
pharmacology & pharmacy (51) 51
anticoagulation (50) 50
thromboembolism (50) 50
deep-vein thrombosis (49) 49
dose-response relationship, drug (48) 48
heparin, low-molecular-weight - therapeutic use (47) 47
blood coagulation - drug effects (45) 45
enoxaparin - administration & dosage (45) 45
surgery (43) 43
anticoagulants - pharmacology (42) 42
apixaban (41) 41
animals (39) 39
risk factors (38) 38
anticoagulants - adverse effects (37) 37
dabigatran (36) 36
prospective studies (36) 36
warfarin (36) 36
administration, oral (34) 34
cardiac & cardiovascular systems (34) 34
pharmacodynamics (33) 33
prophylaxis (32) 32
thrombin (32) 32
treatment outcome (32) 32
aged, 80 and over (31) 31
drug monitoring - methods (31) 31
factor xa - metabolism (31) 31
retrospective studies (31) 31
therapy (31) 31
heparin - therapeutic use (30) 30
heparin, low-molecular-weight - administration & dosage (30) 30
pregnancy (30) 30
anti-xa levels (29) 29
coagulation (29) 29
heparin - pharmacology (29) 29
molecular weight (29) 29
prothrombin time (29) 29
heparin, low-molecular-weight - pharmacology (28) 28
anti-xa assay (27) 27
aptt (27) 27
blood (27) 27
obesity (27) 27
analysis (26) 26
dalteparin (26) 26
fondaparinux (26) 26
safety (26) 26
anticoagulant (25) 25
anticoagulants - blood (25) 25
anticoagulants - pharmacokinetics (25) 25
lmwh (25) 25
enoxaparin - therapeutic use (24) 24
glycosaminoglycans (24) 24
heparin, low-molecular-weight - pharmacokinetics (24) 24
medical examination (24) 24
medicine & public health (24) 24
atrial-fibrillation (23) 23
blood coagulation tests (23) 23
venous thromboembolism - prevention & control (23) 23
venous thrombosis (23) 23
blood coagulation tests - methods (22) 22
factor xa - analysis (22) 22
heparin - administration & dosage (22) 22
thromboembolism - prevention & control (22) 22
venous thrombosis - prevention & control (22) 22
anti-iia (21) 21
drug monitoring (21) 21
hemorrhage - chemically induced (21) 21
activated partial thromboplastin time (20) 20
bleeding (20) 20
care and treatment (20) 20
coagulation assays (20) 20
critical care medicine (20) 20
direct oral anticoagulants (20) 20
fibrinolytic agents - therapeutic use (20) 20
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (420) 420
French (28) 28
Japanese (7) 7
Spanish (7) 7
Russian (6) 6
German (4) 4
Chinese (3) 3
Dutch (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 02/2016, Volume 172, Issue 4, pp. 643 - 644
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 02/2014, Volume 111, Issue 2, pp. 240 - 248
While laboratory monitoring is not required in patients treated with apixaban, a direct factor-Xa inhibitor, assessment of its concentration is useful in some... 
anti-Xa | multicenter study | blood coagulation tests | anticoagulant agents | Apixaban | Blood Coagulation, Fibrinolysis and Cellular Haemostasis | HEALTHY-SUBJECTS | SAFETY | THROMBIN | RIVAROXABAN | TIME | COAGULATION ASSAYS | IMPACT | RECOMMENDATIONS | ORAL ANTICOAGULANTS | PERIPHERAL VASCULAR DISEASE | INHIBITOR | HEMATOLOGY
Journal Article
Annales Francaises d'Anesthesie et de Reanimation, ISSN 0750-7658, 10/2013, Volume 32, Issue 10, pp. 691 - 700
New direct oral anticoagulants (NOAC), inhibitors of factor IIa or Xa, are expected to be widely used for the treatment of venous thromboembolic disease, or in... 
Oral anticoagulant | Surgery | Reversal | Anti-Xa | Emergency | Haemorrhage | Anti-IIa
Journal Article
Chest, ISSN 0012-3692, 06/2008, Volume 133, Issue 6, pp. 141S - 159S
Journal Article
Obstetric Medicine, ISSN 1753-495X, 9/2019, Volume 12, Issue 3, pp. 146 - 150
Background Intravenous unfractionated heparin infusion is often used to minimize the duration of time without anticoagulation around delivery in pregnant... 
heparin monitoring | anti-Xa level | Peripartum | venous thromboembolism
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 04/2019, Volume 76, Issue 8, pp. 505 - 511
Purpose This case series presents 3 patients with acute kidney injury taking apixaban or rivaroxaban and transitioning to a heparin infusion. Summary Case 1... 
heparin | heparin monitoring | ANTICOAGULANTS | anti-Xa levels | PHARMACOLOGY & PHARMACY | acute kidney injury | rivaroxaban | apixaban
Journal Article
Clinics in Chest Medicine, ISSN 0272-5231, 09/2018, Volume 39, Issue 3, pp. 583 - 593
The mainstay of treatment of venous thromboembolism (VTE) is anticoagulation. Direct oral anticoagulants (DOAC) have revolutionized anticoagulation management,... 
P-glycoprotein transport | Andexanet-alfa | Anti-Xa level | CYP3A4 | Direct oral anticoagulant (DOAC) | Idarucizumab | Thrombin time | Venous thromboembolism
Journal Article
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, ISSN 0002-9173, 04/2019, Volume 151, Issue 4, pp. 424 - 432
Objectives To determine the relationship between baseline variations in the partial thromboplastin time (PTT) and the discordance between the PTT and anti-Xa... 
Anticoagulants | ASSAY | methods | Discordance | Anti-Xa | PATHOLOGY | PTT | APTT | MONITORING UNFRACTIONATED HEPARIN | THERAPY | Protamine | Partial thromboplastin time | Blood coagulation tests | Discordant | Heparin
Journal Article